Anticoagulant Bivalirudin Powder Pharmaceutical Bivalirudin Grade Bivalirudin

China Anticoagulant Bivalirudin Powder Pharmaceutical Bivalirudin Grade Bivalirudin, Find details about China Bivalirudin, Bivalirudin Powder from Anticoagulant Bivalirudin Powder Pharmaceutical Bivalirudin Grade Bivalirudin

Basic Info.

Model NO.

Condavo-Bivalirudin

Name

Bivalirudin

Product Name

Bivalirudin Powder

Appearance

White Powder

Color

White Color

Test Method

HPLC UV

Storage

Cool Dry Place

Shelf Life

2 Years

Assay

99%

Grade

Medicine Grade

COA

Available

CAS

128270-60-0

C98h138n24o33

2180.317

Density

1.52

Refractive Index

1.675

Trademark

Condavo

Transport Package

1kg/ Aluminium Bag or 25kg/Drum; as Required

Specification

99%

Origin

Shaanxi

Model NO.

Condavo-Bivalirudin

Name

Bivalirudin

Product Name

Bivalirudin Powder

Appearance

White Powder

Color

White Color

Test Method

HPLC UV

Storage

Cool Dry Place

Shelf Life

2 Years

Assay

99%

Grade

Medicine Grade

COA

Available

CAS

128270-60-0

C98h138n24o33

2180.317

Density

1.52

Refractive Index

1.675

Trademark

Condavo

Transport Package

1kg/ Aluminium Bag or 25kg/Drum; as Required

Specification

99%

Origin

Shaanxi

Product Desciption

Anticoagulant Bivalirudin powder Pharmaceutical Bivalirudin grade Bivalirudin

Anticoagulant Bivalirudin Powder Pharmaceutical Bivalirudin Grade Bivalirudin

Product Name	Bivalirudin
CAS	128270-60-0
Appearance	White crystalline powder
MF	C98H138N24O33
MW	2180.317
Purity	99%
Shelf Life	2 Years

Bivalirudin is a kind of synthetic novel anticoagulants(DTI). It is the direct, specific and reversible inhibitor of thrombin. Its anticoagulant ingredient is a kind of 20 peptides derived from hirudin. Bivalirudin can specifically bind with catalytic site and the anion binding site of whether thrombin that is in the blood circulation or thrombus-bound thrombin, thus directly inhibiting thrombin activity. And its role is characterized by short, reversible. Early clinical studies show that the anticoagulation treatment of bivalirudin is good. And the incidence of bleeding events is low. So its use is safer than traditional heparin therapy. It is mainly used for the prevention of angioplasty interventional treatment of ischemic complications of unstable angina pectoris before and after.

Anticoagulant Bivalirudin Powder Pharmaceutical Bivalirudin Grade Bivalirudin

Anticoagulant Bivalirudin Powder Pharmaceutical Bivalirudin Grade Bivalirudin Alternative medicine as ordinary heparin and platelet glycoprotein IIb/IIIa antagonists.

1. It can significantly reduce the incidence of bleeding in elective PCI patients. The total clinical outcome risk fell 14%.
2. It does not cause antibody-mediated thrombocytopenia.
3. Reversibly bind with thrombin. Short half-life. Hard to develop ischemic and hemorrhagic complications.
4. It is not mainly excreted through the kidneys and can be safely used in patients with renal impairment.

Anticoagulant Bivalirudin Powder Pharmaceutical Bivalirudin Grade Bivalirudin